Topical NSAIDs for Knee Pain
For knee pain due to osteoarthritis, use topical diclofenac as your first-line topical agent—it carries a strong recommendation and provides pain relief equivalent to oral NSAIDs with markedly fewer gastrointestinal adverse events. 1
Primary Recommendation: Topical Diclofenac
- Topical NSAIDs (specifically diclofenac) are strongly recommended for knee osteoarthritis pain by the 2020 VA/DoD guidelines 1
- Diclofenac is the only commercially manufactured topical NSAID currently available in the United States and comes in various formulations 1
- Topical diclofenac is superior to placebo and equivalent to oral diclofenac at reducing knee OA pain 1
- The recommended dose is 40 mg (2 pump actuations) applied to each painful knee twice daily 2
Application Instructions
- Apply to clean, dry skin by dispensing directly onto the knee or first into the hand, then spread evenly around front, back, and sides of the knee 2
- Wash hands completely after application 2
- Avoid showering/bathing for at least 30 minutes after application 2
- Wait until the area is completely dry before covering with clothing (typically wait before covering) 2
- Avoid skin-to-skin contact with others until the treated knee is completely dry 2
Safety Profile Advantage
- Topical NSAIDs have markedly fewer gastrointestinal adverse events compared to oral NSAIDs, though they have substantially more local adverse events (primarily mild skin reactions) 1
- Safety data at 1 year shows consistency with 12-week safety profiles 1
- Local skin irritation occurs in approximately 36% of patients but leads to discontinuation in only 6% 3
Alternative Option: Topical Capsaicin
- Topical capsaicin is conditionally recommended (weak recommendation) for knee OA as a second-line topical agent 1
- Capsaicin (0.025% to 0.075%) works by depleting substance P, reducing pain through a different mechanism than NSAIDs 1, 4
Important Capsaicin Considerations
- Requires continuous use for 2 to 4 weeks before experiencing therapeutic effects—this is a critical counseling point 1, 4
- Initially causes pain and burning sensation at the application site as it triggers substance P release before depletion occurs 1, 4
- Adverse events (burning or stinging) occur at the application site in a significant proportion of patients 1
- Evidence supports at least a moderate effect (standard mean difference 0.44) in reducing moderate knee pain 1
- In clinical trials, patients with both rheumatoid arthritis and osteoarthritis demonstrated mean pain reductions of 57% and 33% respectively after 4 weeks 5
Treatment Algorithm for Knee Pain
- Start with topical diclofenac as first-line topical pharmacotherapy for knee OA 1
- Consider topical capsaicin if patient cannot tolerate topical NSAIDs or as an adjunct therapy 1, 4
- Integrate topical therapy with core non-pharmacological treatments including exercise, weight loss, and physical therapy—topical agents are adjuncts, not replacements 1, 4
- If topical therapy provides inadequate relief, escalate to oral NSAIDs (which remain the mainstay of pharmacological management) 1
Common Pitfalls to Avoid
- Do not use topical NSAIDs for hip pain—the depth of the hip joint beneath the skin surface prevents adequate drug penetration, making topical agents ineffective 1, 6
- Do not discontinue capsaicin prematurely—patients must understand the 2-4 week delay before therapeutic benefit and the initial burning sensation 1, 4
- Do not combine topical and oral NSAIDs routinely unless the benefit outweighs the risk, and conduct periodic laboratory evaluations if combination therapy is used 2
- Do not apply topical NSAIDs to open wounds or allow contact with eyes and mucous membranes 2
- Do not apply external heat or occlusive dressings to treated knees 2
- Do not skip core treatments—topical agents should be part of a comprehensive management plan that includes exercise, weight management, and patient education, not monotherapy 1, 4
When Topical Therapy is Most Appropriate
- Topical NSAIDs should be considered prior to oral NSAIDs following the principle that medications with the least systemic exposure are preferable 1
- Particularly useful for patients aged ≥75 years or those with comorbidities at increased risk of cardiovascular, gastrointestinal, or renal side effects from oral NSAIDs 7
- Most appropriate when only a few joints are affected with mild to moderate pain 4